Co-Diagnostics, Inc. (CODX) Scorecard
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Win.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Win.
32/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 4 wins, 8 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
WinCODX / S&P 66.67% / 15.20% |
LoseCODX / S&P -28.12% / 15.00% |
LoseCODX / S&P -20.51% / 50.40% |
| 2026-Q10/3 |
LoseCODX / S&P -63.31% / -4.33% |
LoseCODX / S&P -79.47% / 11.30% |
LoseCODX / S&P 4.30% / 27.70% |
| 2025-Q41/3 |
LoseCODX / S&P -50.87% / 2.65% |
LoseCODX / S&P -84.10% / 9.00% |
WinCODX / S&P 31.22% / 13.40% |
| 2025-Q32/3 |
WinCODX / S&P 22.86% / 8.12% |
LoseCODX / S&P -93.06% / 4.61% |
WinCODX / S&P 3563.04% / 13.45% |
| 2025-Q21/3 |
LoseCODX / S&P -9.68% / 10.94% |
LoseCODX / S&P -89.02% / 4.83% |
WinCODX / S&P 3924.60% / 10.63% |
| 2025-Q11/3 |
LoseCODX / S&P -58.67% / -4.27% |
LoseCODX / S&P -47.62% / 4.98% |
WinCODX / S&P 3230.30% / 10.57% |
| 2024-Q41/3 |
LoseCODX / S&P -40.00% / 2.41% |
LoseCODX / S&P -42.53% / 5.25% |
WinCODX / S&P 2976.03% / 6.15% |
| 2024-Q31/3 |
LoseCODX / S&P 0.00% / 5.89% |
WinCODX / S&P 57.16% / 5.89% |
LoseCODX / S&P -0.72% / 6.11% |
| 2024-Q22/3 |
WinCODX / S&P 11.61% / 4.28% |
WinCODX / S&P 25.24% / 5.38% |
LoseCODX / S&P 2.44% / 5.12% |
| 2024-Q11/3 |
LoseCODX / S&P -15.79% / 10.56% |
LoseCODX / S&P -44.91% / 5.71% |
WinCODX / S&P 32.00% / 5.59% |
| 2023-Q42/3 |
WinCODX / S&P 25.47% / 11.69% |
LoseCODX / S&P -80.09% / 6.81% |
WinCODX / S&P 163.04% / 7.78% |
| 2023-Q30/3 |
LoseCODX / S&P -4.50% / -3.27% |
LoseCODX / S&P -91.25% / 7.52% |
LoseCODX / S&P -395.74% / -5.03% |
| 2023-Q20/3 |
LoseCODX / S&P -25.00% / 8.74% |
LoseCODX / S&P -90.67% / 9.50% |
LoseCODX / S&P -238.20% / -8.57% |
| 2023-Q10/3 |
LoseCODX / S&P -41.27% / 7.50% |
LoseCODX / S&P -87.95% / 10.77% |
LoseCODX / S&P -176.92% / -15.69% |
| 2022-Q40/3 |
LoseCODX / S&P -21.50% / 7.56% |
LoseCODX / S&P -65.04% / 11.88% |
LoseCODX / S&P -137.70% / -17.99% |
| 2022-Q30/3 |
LoseCODX / S&P -42.78% / -4.88% |
LoseCODX / S&P -49.14% / 13.47% |
LoseCODX / S&P -66.90% / -1.41% |
| 2022-Q21/3 |
WinCODX / S&P -9.22% / -16.10% |
LoseCODX / S&P -18.81% / 13.71% |
LoseCODX / S&P -43.31% / 11.04% |
| 2022-Q10/3 |
LoseCODX / S&P -30.80% / -4.60% |
LoseCODX / S&P 8.10% / 15.97% |
LoseCODX / S&P -25.71% / 42.23% |
| 2021-Q41/3 |
LoseCODX / S&P -8.22% / 11.03% |
WinCODX / S&P 31.30% / 15.00% |
LoseCODX / S&P -15.28% / 96.40% |
| 2021-Q32/3 |
WinCODX / S&P 17.94% / 0.58% |
WinCODX / S&P 120.20% / 10.77% |
LoseCODX / S&P 59.55% / 69.42% |
| 2021-Q22/3 |
LoseCODX / S&P -13.52% / 8.55% |
WinCODX / S&P 274.33% / 6.58% |
WinCODX / S&P 503.85% / 51.81% |
| 2021-Q11/3 |
LoseCODX / S&P 2.58% / 6.17% |
WinCODX / S&P 5185.43% / -1.06% |
LoseCODX / S&P -630.30% / 7.39% |
| 2020-Q41/3 |
LoseCODX / S&P -31.57% / 12.15% |
WinCODX / S&P 34579.90% / -3.72% |
LoseCODX / S&P CODX unavailable / -33.42% |
| 2020-Q31/3 |
LoseCODX / S&P -29.77% / 8.93% |
WinCODX / S&P 40432.04% / -2.04% |
LoseCODX / S&P CODX unavailable / -27.10% |
| 2020-Q22/3 |
WinCODX / S&P 153.94% / 20.54% |
WinCODX / S&P 30006.33% / -0.46% |
LoseCODX / S&P CODX unavailable / -27.11% |
| 2020-Q12/3 |
WinCODX / S&P 751.40% / -19.60% |
WinCODX / S&P 5136.06% / 3.47% |
LoseCODX / S&P CODX unavailable / -14.75% |
| 2019-Q41/3 |
LoseCODX / S&P -13.11% / 9.07% |
WinCODX / S&P 438.63% / 5.36% |
LoseCODX / S&P CODX unavailable / 2.99% |
| 2019-Q32/3 |
WinCODX / S&P 28.11% / 1.70% |
WinCODX / S&P 269.98% / 5.02% |
LoseCODX / S&P CODX unavailable / 0.21% |
| 2019-Q21/3 |
LoseCODX / S&P -24.15% / 4.30% |
WinCODX / S&P 247.70% / 6.64% |
LoseCODX / S&P CODX unavailable / 8.65% |
| 2019-Q11/3 |
LoseCODX / S&P -28.86% / 13.65% |
WinCODX / S&P 93.66% / 8.12% |
LoseCODX / S&P CODX unavailable / 14.29% |
| 2018-Q40/3 |
LoseCODX / S&P -43.35% / -13.52% |
LoseCODX / S&P CODX unavailable / 9.05% |
LoseCODX / S&P CODX unavailable / 18.23% |
| 2018-Q30/3 |
LoseCODX / S&P -32.22% / 7.71% |
LoseCODX / S&P CODX unavailable / 10.21% |
LoseCODX / S&P CODX unavailable / 19.06% |
| 2018-Q21/3 |
WinCODX / S&P 77.98% / 3.43% |
LoseCODX / S&P CODX unavailable / 9.03% |
LoseCODX / S&P CODX unavailable / 14.46% |
| 2018-Q10/3 |
LoseCODX / S&P -17.42% / -0.76% |
LoseCODX / S&P CODX unavailable / 7.68% |
LoseCODX / S&P CODX unavailable / 12.46% |
| 2017-Q40/3 |
LoseCODX / S&P -57.76% / 6.64% |
LoseCODX / S&P CODX unavailable / 7.03% |
LoseCODX / S&P CODX unavailable / 13.82% |
| 2017-Q30/3 |
LoseCODX / S&P CODX unavailable / 4.48% |
LoseCODX / S&P CODX unavailable / 5.68% |
LoseCODX / S&P CODX unavailable / 17.57% |
| 2017-Q20/3 |
LoseCODX / S&P CODX unavailable / 3.09% |
LoseCODX / S&P CODX unavailable / 4.83% |
LoseCODX / S&P CODX unavailable / 17.74% |
| 2017-Q10/3 |
LoseCODX / S&P CODX unavailable / 6.07% |
LoseCODX / S&P CODX unavailable / 3.67% |
LoseCODX / S&P CODX unavailable / 13.32% |
| 2016-Q40/3 |
LoseCODX / S&P CODX unavailable / 3.82% |
LoseCODX / S&P CODX unavailable / 2.09% |
LoseCODX / S&P CODX unavailable / 7.05% |
| 2016-Q30/3 |
LoseCODX / S&P CODX unavailable / 3.85% |
LoseCODX / S&P CODX unavailable / 0.20% |
LoseCODX / S&P CODX unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | CODX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -87.27% | 20.78% |
| Annualized return | -87.27% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | CODX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -99.61% | 83.14% |
| Annualized return | -67.08% | 12.86% |
10Y · 2017-07-12 to 2026-08-27
| Metric | CODX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -99.28% | 319.30% |
| Annualized return | -38.92% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |